Study-Dependent Variability in Spinopelvic Parameters Among Patients Undergoing Total Hip Arthroplasty
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Mayo Clinic
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Change in pelvic tilt (PT)
Study Overview
Brief Summary
This research is being conducted to assess measurement correlations on different X-ray views on patients who have undergone or will undergo hip reconstruction surgery.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 99 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Ability to provide informed consent.
- •40 patients: 20 preoperative THA, 20 postoperative THA;
- •Sex: 20 men, 20 women;
- •Age: 20 patients ≥ 70 years, 10 patients 50-70 years, 10 patients 18-50 years.
Exclusion Criteria
- •Patients with lumbosacral hardware, contralateral THA.
Arms & Interventions
Pre-THA
Subjects will be receiving EOS imaging prior to Total Hip Arthroplasty (THA)
Intervention: EOS X-Ray (Diagnostic Test)
Post-THA
Subjects will be receiving EOS imaging after Total Hip Arthroplasty (THA)
Intervention: EOS X-Ray (Diagnostic Test)
Outcomes
Primary Outcomes
Change in pelvic tilt (PT)
Time Frame: Baseline, 8 hours, 4 weeks
Measured from EOS imaging and AP x-ray, reported in degrees
Change in sacral slope (SS)
Time Frame: Baseline, 8 hours, 4 weeks
Measured from EOS imaging and AP x-ray, reported in degrees
Change in pelvic incidence (PI)
Time Frame: Baseline, 8 hours, 4 weeks
Measured from EOS imaging and AP x-ray, reported in degrees
Change in symphysis to sacrococcygeal junction distance (PSCD)
Time Frame: Baseline, 8 hours, 4 weeks
Measured from EOS imaging and AP x-ray, reported in millimeters (mm)
Change in lumbar lordosis (LL)
Time Frame: Baseline, 8 hours, 4 weeks
Measured from EOS imaging and AP x-ray, reported in degrees
Secondary Outcomes
No secondary outcomes reported
Investigators
Matthew P. Abdel, M.D.
Principal Investigator
Mayo Clinic